Follow POL on Twitter In City Journal, Marie Gryphon explores the need for preemption if the FDA is to stop the problem of overwarning. (I am quoted.) Earlier: Feb. 25; Jan. 2; Mar. 2006.
"Overwarning, Undercuring"
 |
| Isaac Gorodetski Project Manager, Center for Legal Policy at the Manhattan Institute igorodetski@manhattan-institute.org |
 |
| Bridget Carroll Press Officer, Manhattan Institute bcarroll@manhattan-institute.org |
